Very low dose of flutamide in the treatment of hyperandrogenism
Fulghesu, Anna Maria;MELIS, FEDERICA;CANU, ELENA;Melis, Gian Benedetto
2018-01-01
Abstract
Hyperandrogenism is a condition affecting 5–10% of adolescents. The aim of this study was to evaluate the efficacy of very low dose of flutamide in the treatment of hyperandrogenism in adolescence. One hundred and fifty-eight patients, presenting severe acne and/or hirsutism, received 62.5 mg/day of flutamide + ethinylestradiol + gestodene for 18 months. The patients were subjected to assessments of hepatic enzymes levels. Thirty subjects treated with drospirenone + ethinylestradiol represented the control group. After 18 months of treatment, it was obtained a decrease of hirsutism (−39.9%), an almost recovery of acne (98% of patients) with better results of those obtained in control group. Only one case of light hypertransaminasemia was recorded, regressed spontaneously. Very low dose of flutamide was successful and safe and in the treatment of hyperandrogenism in adolescence.File | Dimensione | Formato | |
---|---|---|---|
Very low dose of flutamide in the treatment of hyperandrogenism 2017.pdf Solo gestori archivio
Tipologia: versione post-print (AAM)
Dimensione 796.63 kB
Formato Adobe PDF
|
796.63 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.